Provided By GlobeNewswire
Last update: Jun 4, 2025
PHILADELPHIA and VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces today that the Company will be conducting two virtual investor presentations on Thursday, June 12, at 12:00 PM EDT and on Thursday, June 26, at 12:00 PM EDT, arranged by Renmark Financial Communications Inc. Briacell Therapeutics Corp. welcomes stakeholders, investors, and other individual followers to register and attend these live events.
Read more at globenewswire.comNASDAQ:BCTXW (6/18/2025, 9:30:01 AM)
0.0701
0 (-0.43%)
1.02
+0.03 (+3.18%)
NASDAQ:BCTX (6/18/2025, 10:28:54 AM)
3.115
0 (-0.16%)
Find more stocks in the Stock Screener